Premium
Cis‐platinum vestibular toxicity
Author(s) -
Schaefer Steven D.,
Wright Charles G.,
Post Jimmy D.,
Frenkel Eugene P.
Publication year - 1981
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19810301)47:5<857::aid-cncr2820470508>3.0.co;2-m
Subject(s) - ototoxicity , medicine , vestibular system , nephrotoxicity , toxicity , audiology , cisplatin , oncology , surgery , chemotherapy
Cis‐diamminedichloroplatinum has been proven to be an effective neoplastic agent. Nephrotoxicity and ototoxicity are two prominent side effects of this drug. Investigation of ototoxicity has been limited to auditory function. This report details the first known case of vestibular toxicity following platinum therapy. In addition, a prospective vestibular testing program is reported. Cancer 47:857–8589, 1981.